Pheochromocytoma

Oncology·MeSH: Pheochromocytoma

9 drugs in development·6 companies·5 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
metyrosine	Amneal Pharmaceuticals, Inc. (AMRX)
Welireg	Merck & Co., Inc. (MRK)

Phase 3(1)

Drug	Company
ONC206	Jazz Pharmaceuticals plc (JAZZ)

Phase 2(4)

Drug	Company
Ga-68-DOTATATE	ENANTA PHARMACEUTICALS INC (ENTA)
Lu-177-DOTATATE	ENANTA PHARMACEUTICALS INC (ENTA)
Olaparib	Black Diamond Therapeutics, Inc. (BDTX)
Olaparib	PTC THERAPEUTICS, INC. (PTCT)

Phase 1(2)

Drug	Company
([18F]-6F-DA)	ENANTA PHARMACEUTICALS INC (ENTA)
([18F]-DOPA)	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 9 drugs in development for Pheochromocytoma across 6 companies.

There are 5 clinical trials targeting Pheochromocytoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.